ENIGMATIG LTD Logo

ENIGMATIG LTD

Global expansion and regulatory compliance consultancy for the financial services industry.

EGG | NYSE

Overview

Corporate Details

ISIN(s):
N/A
LEI:
Country:
United States of America
Address:
16 RAFFLES QUAY,, 48581 SINGAPORE
Sector:
Mining and quarrying
Industry:
Mining of non-ferrous metal ores

Description

Enigmatig Ltd is an international business consultancy founded in 2010 that functions as a one-stop service provider for organizations seeking global expansion, with a focus on the financial services industry. The firm specializes in cross-border regulatory compliance and licensing, offering assistance with various financial licenses including brokerage, banking, fund, and insurance. Key services include turnkey solutions for setting up brokerages, FX brokerage consultancy, corporate services such as company formation and talent acquisition, and blockchain solutions. Enigmatig leverages its expertise in FinTech and RegTech to provide tailored strategies and support for clients, primarily financial institutions and SMEs, navigating complex international markets.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all ENIGMATIG LTD filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for ENIGMATIG LTD

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for ENIGMATIG LTD via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
Korean CRO offering end-to-end clinical trial services for pharma & bio ventures.
South Korea 187660
HYUNDAI BIOSCIENCE CO., LTD. Logo
Clinical-stage biotech developing safer antiviral & anticancer drugs via advanced drug delivery systems.
South Korea 048410
iBio, Inc. Logo
AI-powered biotech developing antibody therapeutics for cardiometabolic diseases and obesity.
United States of America IBIO
Ibotta, Inc. Logo
A performance marketing platform offering cash-back rewards to consumers from CPG brands.
United States of America IBTA
ICON PLC Logo
Global CRO providing outsourced development & commercialization for pharma, biotech & device firms.
United States of America ICLR
IDEAYA Biosciences, Inc. Logo
Clinical-stage firm developing precision cancer therapies via synthetic lethality.
United States of America IDYA
IMGT Corporation Limited Logo
Develops a drug delivery platform using ultrasound and nanotech for oncology.
South Korea 456570
IMMERSION CORP Logo
Licenses patented haptic feedback technology for mobile, gaming, and automotive interfaces.
United States of America IMMR
IMMUNIC, INC. Logo
Developing oral small molecule therapies for chronic inflammatory and autoimmune diseases.
United States of America IMUX
IMMUTEP Ltd Logo
Developing LAG-3-based immunotherapies for cancer and autoimmune diseases.
United States of America IMMP

Talk to a Data Expert

Have a question? We'll get back to you promptly.